Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Group President | November 11, 2019 | November 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date November 11, 2019 · Filed November 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 757 |
Ending reported balance
After 2019-11-11 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2019-11-11 · Exercise / conversion · Acquired 3,150 · Balance 3,907 Row 2 · 2019-11-11 · Sale · Disposed 3,150 · Balance 757 F1: Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Row 3 · 2019-11-11 · Exercise / conversion · Acquired 4,718 · Balance 5,475 Row 4 · 2019-11-11 · Sale · Disposed 4,718 · Balance 757 F2: Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Row 5 · 2019-11-11 · Exercise / conversion · Acquired 1,613 · Balance 2,370 Row 6 · 2019-11-11 · Sale · Disposed 1,613 · Balance 757 F3: Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Row 7 · 2019-11-11 · Exercise / conversion · Acquired 2,910 · Balance 3,667 Row 8 · 2019-11-11 · Sale · Disposed 2,910 · Balance 757 F4: Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Row 9 · 2019-11-11 · Exercise / conversion · Acquired 2,780 · Balance 3,537 Row 10 · 2019-11-11 · Sale · Disposed 2,780 · Balance 757 F5: Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $113.83 · Expires 2025-06-24 | Direct | 0 |
Reported balance
After 2019-11-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-11-11 · Exercise / conversion · Disposed 3,150 · Balance 0 F6: One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $104.01 · Expires 2026-03-21 | Direct | 1,572 |
Reported balance
After 2019-11-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2019-11-11 · Exercise / conversion · Disposed 4,718 · Balance 1,572 F7: 4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $103.25 · Expires 2027-01-03 | Direct | 1,612 |
Reported balance
After 2019-11-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2019-11-11 · Exercise / conversion · Disposed 1,613 · Balance 1,612 F8: 806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $121.88 · Expires 2027-03-21 | Direct | 2,910 |
Reported balance
After 2019-11-11 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2019-11-11 · Exercise / conversion · Disposed 2,910 · Balance 2,910 F9: 1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.44 · Expires 2028-03-20 | Direct | 8,340 |
Reported balance
After 2019-11-11 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2019-11-11 · Exercise / conversion · Disposed 2,780 · Balance 8,340 F10: 2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F2: Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F3: Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F4: Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F5: Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F6: One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019.
F7: 4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020.
F8: 806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021.
F9: 1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021.
F10: 2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,780 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 15 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,340 Underlying: Common Stock · 2,780 shares Expires 2028-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: 2,780 options vested on March 20, 2019; and the remaining unvested options will vest in equal portions on each of March 20, 2020, March 20, 2021 and March 20, 2022. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,910 | $0.00 Strike: $121.88 | $0.00 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 14 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 2,910 shares Expires 2027-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: 1,455 options vested on each of March 21, 2018 and March 21, 2019; and the remaining unvested options will vest in equal portions on each of March 21, 2020 and March 21, 2021. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,613 | $0.00 Strike: $103.25 | $0.00 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 13 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,612 Underlying: Common Stock · 1,613 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 806 options vested on January 3, 2018; 807 options vested on January 3, 2019; and the remaining unvested options will vest in equal portions on each of January 3, 2020 and January 3, 2021. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,718 | $0.00 Strike: $104.01 | $0.00 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 12 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,572 Underlying: Common Stock · 4,718 shares Expires 2026-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 4,718 of the options vested in thirds on each of March 21, 2017, March 21, 2018 and March 21, 2019; and the remaining unvested options will vest on March 21, 2020. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,150 | $0.00 Strike: $113.83 | $0.00 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · derivative · entry 11 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,150 shares Expires 2025-06-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth of the options vested on each of June 24, 2016, June 24, 2017, June 24, 2018 and June 24, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 2,780 | $141.14 | $392,369.20 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 10 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F5 · price: Represents the sale of 2,780 shares in multiple transactions ranging in price from $140.995 to $141.59 per share, resulting in a weighted average sale price of $141.14. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,780 | $114.44 | $318,143.20 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 9 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 2,910 | $141.17 | $410,798.88 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 8 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F4 · price: Represents the sale of 2,910 shares in multiple transactions ranging in price from $141.065 to $141.505 per share, resulting in a weighted average sale price of $141.168. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,910 | $121.88 | $354,670.80 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 7 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,613 | $141.48 | $228,199.18 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 6 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F3 · price: Represents the sale of 1,613 shares in multiple transactions ranging in price from $141.00 to $141.72 per share, resulting in a weighted average sale price of $141.475. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,613 | $103.25 | $166,542.25 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 5 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 4,718 | $141.24 | $666,384.47 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 4 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F2 · price: Represents the sale of 4,718 shares in multiple transactions ranging in price from $141.005 to $141.64 per share, resulting in a weighted average sale price of $141.243. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 4,718 | $104.01 | $490,719.18 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 3,150 | $141.31 | $445,113.90 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F1 · price: Represents the sale of 3,150 shares in multiple transactions ranging in price from $140.98 to $141.595 per share, resulting in a weighted average sale price of $141.306. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 3,150 | $113.83 | $358,564.50 |
DisclosureSEC source: 0000911916-19-000184 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · derivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 163 | $127.03 | $20,705.89 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 10,446 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000061 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,446 Underlying: Common Stock · 10,446 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000047 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 Underlying: Common Stock · 666 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019. F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000011 · edgar.xml · derivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370 Underlying: Common Stock · 185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The RSUs vest as follows: 185 vested on January 3, 2018; 185 vested on January 3, 2019; and of the remaining 370 RSUs, 185 RSUs are scheduled to vest on each of January 3, 2020 and January 3, 2021. F3 · derivative.expiration_date: The RSUs vest as follows: 185 vested on January 3, 2018; 185 vested on January 3, 2019; and of the remaining 370 RSUs, 185 RSUs are scheduled to vest on each of January 3, 2020 and January 3, 2021. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 55 | $101.23 | $5,567.65 |
DisclosureSEC source: 0000911916-19-000011 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000011 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 20:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 11,120 | $0.00 Strike: $114.44 | $0.00 |
DisclosureSEC source: 0000911916-18-000064 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,120 Underlying: Common Stock · 11,120 shares Expires 2028-03-20 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on March 20, 2019. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:34 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 11,765 | $0.00 Strike: $119.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000039 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Underlying: Common Stock · 11,765 shares Expires 2028-02-20 Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · derivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555 Underlying: Common Stock · 185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: The 740 RSUs in this grant vest annually over four years in increments of 25% each year, commencing January 3, 2018. F3 · derivative.expiration_date: The 740 RSUs in this grant vest annually over four years in increments of 25% each year, commencing January 3, 2018. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Tax withholdingCommon Stock | 61 | $124.68 | $7,605.18 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 F1 · shares: Represents shares withled by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000020 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.